Effectiveness of Focused Shockwave Therapy versus Radial Shockwave Therapy for Noncalcific Rotator Cuff Tendinopathies: A Randomized Clinical Trial
This report has been verified
by one or more authors of the
original publication.
OrthoEvidence Journal (OE Journal) - ACE Report
OE Journal. 2021;9(4):16 Biomed Res Int. 2021 Jan 9;2021:6687094What this means for my practice?
Study findings may suggest that in patients with noncalcific rotator cuff tendinopathy, focused shockwave therapy can perhaps provide significant advantages in pain reduction and functional improvement over radial shockwave therapy at 24-48 weeks after treatment. This study was limited by the differences in energy level between the two treatments: the F-SWT was applied at a lower energy relative to the R-SWT, which may have influenced the results. Moreover, the sample size was very small. Future studies with larger sample sizes examining differing frequencies and energy levels are of interest to identify the optimal protocol for shockwave therapy in the treatment of noncalcific rotator cuff tendinopathy.
Study Summary
Forty-six patients with non-calcific rotator cuff tendinopathy were randomized to receive 4 weekly sessions of focused shockwave therapy (F-SWT; n=23) or radial shockwave therapy (R-SWT; n=23) for the improvement of symptoms. The primary outcome of interest was pain evaluated on a Numeric Rating Scale (NRS) at 24 weeks. Secondary outcomes of interest included the Constant-Murley Scale (CMS) total score and associated sub-score (i.e., pain, activities of daily living [ADL], range of motion, and power), and NRS pain scores. All outcomes were assessed at 4, 12, 24, and 48 weeks post-treatment. Results revealed statistically significantly lower NRS pain scores at 24 and 48 weeks in favour of the F-SWT group compared to the R-SWT group (p<0.001 for both). Similarly, CMS total scores, pain sub-scores, and ADL sub-scores were statistically significantly in favour of the F-SWT group at 24 and 48 weeks post-treatment (p<0.05 for all). Moreover, the CMS range of motion sub-scores were statistically significantly in favour of the F-SWT group at 48 weeks only (p=0.035). No statistical significant differences were observed between the two groups in the CMS power sub-scores at any timepoint (p>0.05 for all). In addition, 5 cases of moderate pain, 1 case of syncope, and 2 cases of redness were reported in the F-SWT group, whilst 3 cases of moderate pain and 1 case of migraine were reported in the R-SWT group.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
Are you affiliated with one of our partner associations?
Click here to gain complimentary access as part your association member benefits!
